Endocrine Community
Get answers. Share advice. Learn More

Cost effectiveness of preoperative sestamibi scanning for patents with primary hyperparathyroidism is solely dependent upon the surgeon's choice of operative procedure.

Daphne Denham, M.D., and James Norman, M.D., F.A.C.S.

This study was presented at the 1997 Annual Meeting of the American College of Surgeons. The manuscript was published in the Journal of the American College of Surgeons 1998; 186:293-304.

Due to space limitations, the entire 206 citations of this extensive literature review and Meta-Analysis could not be included in the manuscript. The authors have made these citations available here for those wanting a further reference of what they believe are all articles published on the topic of primary hyperparathyridism in the English literature from January, 1986 through October, 1997.

  1. Achong DM, Oates E. Tc-99m sestamibi uptake by parathyroid carcinoma: False-positive localization of parathyroid adenoma. Clinical Nuclear Medicine. 1995;8:735.
  2. Adler LP, Akhrass R, Ma D, Bloom AD. False-positive parathyroid scan leading to sternotomy: Incidental detection of a thymoma by C-11 methionine positron emission tomography. Surg 1997;122:116-119.
  3. Akerstrom G, Rudberg C, Grimelius L, Johansson H, Lundstrom B, Rastad J. Causes of failed primary exploration and technical aspects of re-operation in primary hyperparathyroidism. World J Surg 1992;16:562-569.
  4. Akerstrom G. Non-familial primary hyperparathyroidism. Semin Surg Oncol 1997;13:104-113.
  5. al Zahrani A, et al. Primary hyperparathyroidism. Lancet 1997;349:1233-1238.
  6. Arbab AS, Koizumi K, Hemmi A, Toyama K, Arai T, Yoshitomi T, Araki T. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med 1997;11:45-49.
  7. Arkles LB, Jones T, Hicks RJ, DeLuise MA, Chou ST. Impact of complementary parathyroid scintigraphy and ultrasonography on the surgical management of hyperparathyroidism. Surg. 1996;120:845-51.
  8. Attie JN, Bock G, Auguste LJ. Multiple parathyroid adenomas: Report of thirty-three cases. Surg. 1990;108:1014-20.
  9. Attie JN, Khan A, Rumancik WM, Moskowitz GW, Hirsch MA, Herman PG. Preoperative localization of parathyroid adenomas. Am J Surg 1988;156:323-326.
  10. Attie JN. Primary hyperparathyroidism. Curr Ther Endocrinol Metab 1997;6:557-564.
  11. Auguste LJ, Attie JN, Schnaap D. Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg 1990; 160:333-6.
  12. Ballard JL, Deiparine MK, Bergan JJ, Bunt TJ, Killeen JD, Smith LL. Cost-effective evaluation and treatment for carotid disease. Arch Surg 1997;132:268-271.
  13. Bennedbaek FN, et al. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 1997;136:240-250.
  14. Billotey C, Aurengo A, Najean Y, sarfati E, Moretti JL, Toubert ME, Rain JD. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures. J Nucl Med 1994;35:1631-1636.
  15. Billotey C, Sarfati E, Aurengo A, Duet M, Mundler O, Toubert ME, Rain JD, Najean Y. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996;37:1773-1778.
  16. Billy HT, Rimkus DR, Hartzman S, Latimer RG. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism. Am Surg 1995;61:882-888.
  17. Bergenfelz A, Tennvall J, Valdermarsson S, Lindblom P, Tibblin S. Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: A prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery 1997;121:601-605.
  18. Bergenfelz A, Algotsson L Ahren B. Surgery for primary hyperparathyroidism performed under local anesthesia. Br. J. Surg. 1992;79:931-934.
  19. Blocklet D, et al. Presurgical localization of abnormal parathyroid glands using a single injection of technetium-99m methoxyisobutylisonitrile: comparison of diefferent techniques including factor analysis of dynamic structures. Eur J Nucl Med 1997;24:46- 51.
  20. Bondeson AG, Bondeson L, Busch C, Grimelius L, Ljungberg O. ABO blood group antigens in parathyroid adenoma and hyperplasia. Surg 1989;105:734-736.
  21. Bonjer HJ, Bruining HA, Valkema R, Lameris JS, Herder WW, van der Harst E, Pols H. Single radionuclide scintigraphy with 99m technetium-sestamibi and ultrasonography in hyperparathyroidism. Eur J Surg 1997;163:27-32.
  22. Bonjer HJ, Bruining HA, Pols HAP, deHerder WW, vanEijck CHJ, Breeman WAP, Krenning EP. Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer. Eur J Nucl Med 1997;24:246-251.
  23. Bonjer HJ, Bruining HA, Birkenhager JC, Nishiyama RH, Jones MA, Bagwell CB. Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology, and flow cytometric DNA analysis. World J Surg 1992;16:737-744.
  24. Borley NR, Collins REC, O'Doherty M, Coakley A. Technetium-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration. Br J Surg 1996;83:989-991.
  25. Broadie TA. Location, location, location. Am Surg. 1997;63:567-572.
  26. Bruining HA, van Houten H, Juttman JR. Results of operative treatment of 615 patients with primary hyperparathyroidism. World J Surg 1981;5:85.
  27. Bruining HA, Birkenhager JC, Ong GL, Lamberts SW. Causes of failure in operations for hyperparathyroidism. Surg. 1987;101:562-565.
  28. Bugis SP, Berno E, Rusnak CH, Chu D. Technetium99m-sestamibi scanning before initial neck exploration in patients with primary hyperparathyroidism. Eur Arch Otorhinolaryngol 1995;252:149-152.
  29. Burmeister LA, et al. Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism. Cancer 1997;79:1611-1616.
  30. Cagir B, Mahoney WD, Hayes JR, Otsu I, Gayola G. Supernumerary ectopic parathyroid adenoma: case report and review literature. Contemporary Surgery 1996;49:337-342.
  31. Caixas A, Berna L, Hernandez A, Tebar FJ, Madariaga P, Vegazo O, Bittini AL, Moreno B, Faure E, Abos D, Piera J, Rodriguez JM, Farrerons J, Puig-Domingo M. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surg. 1997;121:535-41.
  32. Caixas A, Berna L, Piera J, Rigla M, Matias-Guiu X, Farrerons J, Puig-Doming M. Utility of 99mTc- sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clinical Endocrinology 1995;43:525-530.
  33. Caravalho J, Balingit AG, Rivera-Rodriguex JE, Shriver CD, Koops MK. Localization of an ectopic parathyroid adenoma by double-phase technetium-99m-sestamibi scintigraphy. J Nucl Med 1995;36:1840- 1842.
  34. Carter WB, Sarfati MR, Fox KA, Patton DD. Preoperative detection of sporadic parathyroid adenomas using technetium-99m-sestamibi: What role in clinical practice? Am Surg 1997;63:317-321.
  35. Carty SE, Norton JA. Management of patients with persistent or recurrent primary hyperparathyroidism. World J Surg 1991;15:716-723.
  36. Casas AT, Burke GJ, Sathyanarayana, Mansberger AR, Wei JP. Prospective comparison of technetium- 99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Am J Surg 1993;166:369-373.
  37. Casas AT, Burke GJ, Mansberger AR, Wei JP. Impact of Technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 1994;60:12-17.
  38. Chapuis Y, Fulla Y, Bonnichon P, Tarla E, Abboud B, Pitre J, Richard B. Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism. World J. Surg. 1996;20:835-840.
  39. Chen CC, Premkumar A, Hill SC, Skarulis MC, Spiegel AM. Tc-99m sestamibi imaging of a hyperfunctioning parathyroid autograft with doppler ultrasound and MRI correlation. Cl Nucl Med 1995;20:222-225.
  40. Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997;38:834-839.
  41. Chen EM, Mishkin FS. Parathyroid hyperplasia may be missed by double-phase Tc-99m Sestamibi scintigraphy alone. Cl Nucl Med 1997;22:222-226.
  42. Cheung AH, Wheeler MS, Madanay LD, Hew E, Coel MN, Wong LM. Multi-center sestamibi parathyroid imaging study in Hawaii. Hawaii Medical Journal 1997;56:114-120.
  43. Chiu NT, Cheng HM, Yao WJ. Tc-99m sestamibi scanning in the preoperative localization of mediastinal parathyroid adenomas. Ann Nucl Med 1995;9:157-159.
  44. Christiansen P. Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 1997;21:93-99.
  45. Coakley AJ. Parathyroid localization-how and when? Eur J Nucl Med 1991;18:151-152.
  46. Coakley AJ, Kettle AG, Wells P, et al. 99Tcm sestamibi--a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794.
  47. Conn JM, Goncalves MA, Mansour KA, McGarity WC. The mediastinal parathyroid. Am Surg 1991;57:62-66.
  48. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement. Ann Int Med 1994;114:593-597.
  49. Czerniak A, Zwas ST, Shustik O, Avigad I, Ayalon A, Dolev E. The use of radioiodinated toluidine blue for preoperative localization of parathyroid pathology. Surg 1991;110:832-838.
  50. Davis RK, Hoffman J, Dart D, Datz FL. Unilateral parathyroidectomy: The role of thallium-technetium subtraction scans. Oto Head Neck Surg 1990;102:635-638.
  51. Debruyne F, Ostyn F, Delaere P. Distribution of the solitary adenoma over the parathyroid glands. J Laryngology and Otology 1997;111:459-460.
  52. de la Cruz Vigo F, et al. Pathologic intrathyroidal parathyroid glands. Int Surg 1997;82:87-90.
  53. Ditkoff BA, Chabot J, Feind C, Gerfo PL. Parathyroid surgery using monitored anesthesia care as an alternative to general anesthesia. Am J Surg 1996;172:698-700.
  54. Doherty GM, Weber B, Norton JA. Cost of unsuccessful surgery for primary hyperparathyroidism. Surgery. 1994;116:954-8.
  55. Doppman JL, Miller DL. Localization of parathyroid tumors in patients with asymptomatic hyperparathyroidism and no previous surgery. Journal of Bone and Mineral Research 1991;6:S153-S159.
  56. Doppman J. Reoperative parathyroid surgery: Localization procedures, parathyroid surgery. Progr Surg 1986;18:117-136.
  57. Doppman JL, Skarulis MC, Chen CC, Chang R, Pass HI, Fraker DL, Alexander R, Niederle B, Marx SJ, Norton JA, Wells SA, Spiegel AM. Parathyroid adenomas in the aortopulmonary window. Radiology 1996;201:456-462.
  58. Duh QY, Uden P, Clark OH. Unilateral neck exploration for primary hyperparathyroidism: analysis of a controversy using a mathematical model. World J Surg 1992;16:654-662.
  59. Ebisuno S, et al. Preoperative localization of parathyroid adenomas using 99mTc-MIBI scintigraphy in patients with hyperparathyroidism. Int J Urol 1997;4:126-129.
  60. Elkis H, Friedman L, Wise A, Meltzer HY. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorder: comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 1995;52:735-746.
  61. Farley DR, vanHeerden JA, Grant CS. Are concomitant surgical procedures acceptable in patients undergoing cervival exploration for primary hyperparathyroidism? Mayo Clin Proc 1991;66:681-685.
  62. Fayet P, et al. Technetium-99m sestamibi scintigraphy, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism. Br J Radiol 1997;70:459-464.
  63. Feldman EC, et al. Comparison of results of hormonal analysis of samples obtained from selected venous sites versus cervical ultrasonography for localizing parathyroid masses in dogs. J Am Vet Med Assoc 1997;211:54-56.
  64. Fjeld JG, Erichsen K, Pfeffer PF, Clausen OPF, Rootwelt K. Technetium-99m-Tetrofosmin for parathyroid scintigraphy: A comparison with Sestamibi. J Nucl Med 1997;38:831-834.
  65. Freitas JE, Freitas AE. Thyroid and parathyroid imaging. Seminars in Nuc Med 1994;24:234-245.
  66. Gallowitsch HJ, et al. Preoperative scintigraphic and intraoperative scintimetric localization of parathyroid adenoma with cationic Tc-99m complexes and a hand-held gamma-probe. Nuklearmedizin 1997;36:13-18.
  67. Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg 1997;21:287-291.
  68. Goretzki PE, Dotzenrath C, Roeher HD. Management of primary hyperparathyroidism caused by multiple gland disease. World J Surg 1991;15:693-697.
  69. Grimelius L, Akerstrom G, Bondeson L, Juhlin C, Johansson H, Ljunghall S, Rastad J. The role of the patholist in diagnosis and surgical decision making in hyperparathyroidism. World J Surg 1991;15:698- 705.
  70. Halvorson DJ, Burke GJ, Mansberger AR, Wei JP. Use of technetium Tc 99m sestamibi and iodine 123 radionuclide scan for preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism. S Med J 1994;87:336-339.
  71. Harrison BJ, Wheeler MH. Asymptomatic primary hyperparathyroidism. World J Surg 1991;15:724-729.
  72. Harrison TS, Duarte B, Reitz RE, Princenthal R, Seaton JF, Badder E, Graham WP. Primary hyperparathyroidism: four- to eight-year postoperative follow-up demonstrating persistent functional insignificance of microscopic parathyroid hyperplasia and decreased autonomy of parathyroid hormone release. Ann Surg 1981;194:429-437.
  73. Hasselgren PO, Fidler JP. Further evidence against the routine use of parathyroid ultrasonography prior to initial neck exploration for hyperparathyroidism. Am J Surg 1992;164:337-340.
  74. Hedback G, Oden A, Tisell LE. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991;15:399-407.
  75. Heller KS, Attie JN, Dubner S. Parathyroid localization: Inability to predict multiple gland involvement. Am J Surg. 1993;166:357-359.
  76. Hiatt JR, Hiatt N. The parathyroid saga: Gland, hormone and adenoma. Contemporary Surgery 1995;47:332-336.
  77. Hindie E, Melliere D, Simon D, Perlemuter L, Galle P. Primary hyperparathyroidism: Is technetium- sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? Journal of Clinical Endocrinology and Metabolism. 1995;80:302-7.
  78. Hindie E, Melliere D, Perlemuter L, Jeanguillaume C, Galle P. Primary hyperparathyroidism: Higher success rate of first surgery after preoperative Tc-99m Sestamibi-I-123 subtraction scanning. Radiology 1997;204:221-228.
  79. Hodin RA, et al. Detection and management of parathyroid tumors. Curr Opin Oncl 1997;9:75-78.
  80. Irvin GL, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SKC. A new approach to parathyroidectomy. Ann. Surg. 1994;219:574-81.
  81. Irvin GL, Deriso GT. A new, practical intraoperative parathyroid hormone assay. Am Jour Surg. 1994;168:466-468.
  82. Irvin GL, Sfakianakis G, Yeung L, Deriso G, Fishman LM, Molinari AS, Foss JN. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 1996;131:1074-1078.
  83. Ishibashi M, Nishida H, Kumabe T, Morita S, Matoba F, Normura G, Hayabuchi N. Tc-99m tetrofosmin: A new diagnostic tracer for parathyroid imaging. Cl Nuc Med 1995;20:902-905.
  84. Jarhult J, Nordenstrom J and Perbeck L. Reoperation for suspected primary hyperparathyroidism. Br J Surg 1993;80:453-456.
  85. Jaskowiak N, Norton JA, Alexander HR, Doppman JL, Shawker T, Skarulis M, Marx S, Spiegel A, Fraker DL. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 1996;224:308-322.
  86. Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand LW, Besser GM, Grossman AB. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996;81:346-352.
  87. Kairaluoma MI, Makarainen H, Salo-Zetterman E, Kairaluoma MV, Stahlberg M. Cost effectiveness of ultrasound in primary parathyroid surgery. Br J Surg 1989;76:596-597.
  88. Kao PC, van Heerden JA, Grant CS, Klee GG, Khosla S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clinic Proceedings 1992;67:637-645.
  89. Kaplan E, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s: Choice of surgical procedures for this disease. Ann Surg 1992;215:300-317.
  90. Khan A, Samtani S, Varma VM, Frost A, Cohen J. Preoperative parathyroid localization: prospective evaluation of technetium 99m sestamibi. Otolaryngol Head Neck Surg 1994;111:467-72.
  91. Kipper MS, LaBarbera JJ, Krohn LD, Marcou LM. Localization of a parathyroid adenoma by the addition of pinhole imaging to Tc-99m Sestamibi dual-phase scinigraphy. Cl Nuc Med 1997;22:73-75.
  92. Koslin DB, et al. Preoperative evaluation of patients with primary hyperparathyroidism: role of high-resolution ultrasound. Laryngoscope 1997;107:1249-1253.
  93. Kotzmann H et al. Effect of successful parathyroidectomy on hematopoietic progenitor cells and of red blood cells in patients with primary hyperparathyroidism. Horm Metab Res 1997;29:387-392.
  94. Lafferty FW. Differential diagnosis of hypercalcemia. Journal of Bone and Mineral Research 1991;6(suppl2);s51-s61.
  95. Lee VS, Wilkinson RH, Leight GS, Coogan AC, Coleman RE. Hyperparathyroidism in high-risk surgical patients: Evaluation with double-phase Technetium-99m Sestamibi imaging. Radiology 1995;197:627- 633.
  96. Leslie WD, Riese KT, Dupont JO, Peterdy AE. Parathyroid adenomas without sestamibi retention. Cl Nuc Med 1995;20:699-702.
  97. Leslie WD, Riese KT, Guzman R, Dupont JO, Peterdy AE. Technetium-99m-pertechnetate uptake by intrathyroidal parathyroid adenoma. J Nucl Med 1996;37:861-862.
  98. Levin KE, Clark OH. The reasons for failure in parathyroid operations. Arch Surg.1989;124:911-915.
  99. Levin KE, Gooding AW, Okerlund M, Higgins CB, Norman D, Newton TH, Duh QY, Arnaud CD, Siperstein AE, Zeng QH, Clark OH. Localizing studies in patients with persistent or recurrent hyperparathyroidism. Surg. 1987;102:917-925.
  100. Levine MA, Dempsey MA, Helman LJ, Ahn TG. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1990;70:1668-1673.
  101. Liechty RD, Wei R. Parathyroid anatomy in hyperplasia. Archives of Surgery 1992;127:813-816.
  102. Light VL, McHenry CR, Jarjoura D, Sodee DB, Miron SD. Prospective comparison of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg 1996;62:562-568.
  103. LiVolsi VA, Hamilton R. Intraoperative assessment of parathyroid gland pathology: a common view from the surgeon and the pathologist. Am J Cl Path 1994;102:365-373.
  104. Ljunghall S, Hellman P, Rastad J, Akerstrom G. Primary hyperparathyroidism: Epidemiology, diagnosis and clinical picture. World J. Surg. 1991;15:681-687.
  105. Lucas RJ, Welsh RJ, Glover JL. Unilateral neck exploration for primary hyperparathyroidism. Arch Surg 1990;125:962-965.
  106. Lundgren EC, Gillott AR, Wisman JS, Beck J. The role of preoperative localization in primary hyperparathyroidism. Am. Surg. 1995;61:393-96.
  107. Malhotra A, Silver CE, Deshpande V, Freeman LM. Preoperative parathyroid localization with sestamibi. Am J Surg. 1996;172:637-40.
  108. Martin D, Rosen IB, Ichise M. Evaluation of single isotope technetium 99m sestamibi in localization efficiency for hyperparathyroidism. Am J Surg. 1996;172:633-636.
  109. Martinez DA, King DR, Romshe c, Lozano RA, Morris JD, O'Dorisio MS, Martin E. Intraoperative identification of parathyroid gland pathology: a new approach. Journal of Pediatric Surgery 1995;30:1306- 1309.
  110. Massachusetts General Hospital Series. In: Silverberg SG, ed. Surgical Pathology. Vol 2. New York: John Wiley and Sons; 1983:1445-8.
  111. McBiles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid imaging. Seminars in Nuclear Medicine. 1995;25(3):221-34.
  112. McHenry CR. "Same-day" thyroid surgery: An analysis of safety, cost savings, and outcome. Am Surg 1997;586-590.
  113. McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB. Parathyroid localization with technetium- 99m-sestamibi: A prospective evaluation. J Am Coll Surg 1996;183:25-30.
  114. McHenry CR, Pollard A, Walfish PG, Rosen IB. Intraoperative parathormone level measurement in the management of hyperparathyroidism. Surg 1990;108:801-808.
  115. McIntyre RC, Kumpe DA, Liechty D. Reexploration and angiographic ablation for hyperparathyroidism. Arch Surg 1994;129:499-505.
  116. Mendoza V, et al. Primary hyperparathyroidism due to parathyroid carcinoma. Arch Med Res 1997;28:303-306.
  117. Miccoli P, et al. Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism. J Endocrinol Invest. 1997;20:429-430.
  118. Miller DL. Pre-operative localization and interventional treatment of parathyroid tumors: when and how? World J Surg 1991;15:706-715.
  119. Mitchell BK, Merrell RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Surgical Clinics of North America 1995;75:483-498.
  120. Mitchell BK, Cornelius EA, Zoghbi S, Murren JR, Ghoussoub R, Flynn SD, Kinder BK. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surg 1996;120:1039-1045.
  121. Monchik JM. Presidential address: normocalcemic hyperparathyroidism. Surgery 1995;118(6):917-923.
  122. Nanes MS, O'Connor DT, Marx SJ. Plasma chromogranin-A in primary hyperparathyroidism. J Clin Endocrinol Metab 1989;69:950-955.
  123. Neumann DR, Esselstyn CB, Kim EY, Go RT, Obuchowski NA, Rice TW. Preliminary experience with double-phase SPECT using Tc-99m Sestamibi in patients with hyperparathyroidism. Cl Nuc Med 1997;22:217-221.
  124. Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996;37:1809-1815.
  125. Ng DC, et al. Radionuclide imaging in primary hyperparathyroidism using 99mTc sestamibi--four case reports. Singapore Med J 1996;37:585-587.
  126. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1004.
  127. Norman J, Chheda H, Farrell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: Decreasing operative time and potential complications while improving cosmetic results. Am Surg. In press 1998.
  128. Norman J. The technique of intraoperative nuclear mapping to facilitate minimally invasive parathyroidectomy. Cancer Control 1997;4:500-504.
  129. Norton JA. Controversies and advances in primary hyperparathyroidism. Ann. Surg. 1992;215:126-128.
  130. Nottingham JM, Brown JJ, Bynoe RP, et al. Bilateral neck exploration for primary hyperparathyroidism. Am Surg. 1993;59:115-119.
  131. Nussbaum SR, Potts JT. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism. Journal of Bone and Mineral Research 1991;6(suppl2):s43-s50.
  132. O'Doherty MJ. Editorial: Radionuclide parathyroid imaging. J Nucl Med 1997;38:840-841.
  133. O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m- sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313-318.
  134. Ohno K, et al. Mediastinoscopic extirpation of mediastinal ectopic parathyroid gland. Ann Thorac Surg 1997;64:238-240.
  135. Palmer M, Adami HP, Bergstrom R, Akerstrom G, Ljunghall S. Mortality after surgery for primary hyperparathyroidism: A follow-up of 441 patients operated on from 1956 to 1979. Surg 1987;102:1-7.
  136. Peeler BB, Martin WH, Sandler MP, Goldstein RE. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: Development of an optimal localization strategy. Am Surg 1997;63:37-46.
  137. Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE, Clarke MR. Parathyroid adenomas: Accurate detection and localization with Tc-99m Sestamibi SPECT. Radiology 1996;201:85- 91.
  138. Quin JD, et al. Remission of non-insulin-dependent diabetes mellitus following resection of a parathyroid adenoma. Diabet Med 1997;14:80-81.
  139. Prinz RA. Parathyroidectomy and more. Mayo Clin Proc 1991;66:756-759.
  140. Proye CA, Carnaille B, Bizard JP, Quievreux JL, Lecomte-Houcke M. Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: Where are we in the early 1990s? A plea against unilateral parathyroid exploration. Surgery 1992;112:1118-22.
  141. Rafferty MA, et al. Cervical exploration for primary hyperparathyroidism--A 25 year experience. Ir Med J. 1997;90:188-189.
  142. Rantis PC, Prinz RA, Wagner RH. Neck radionuclide scanning: A pitfall in parathyroid localization. Am Surg 1995;61:641-646.
  143. Robertson GS, Johnson PR, Bolia A, Iqbal SJ, Bell PR. Long-term results of unilateral neck exploration for preoperatively localized nonfamilial parathyroid adenomas. Am J Surg. 1996;172:311-314.
  144. Rodriqurz JM, Tezelman S, Siperstein AE, Duh Qy, Higgins C, Morita E, Dowd CF, Clark OH. Localization procedures in patients with persistent or recurrent hyperparathyroidism. Arch Surg 1994;129:870-875.
  145. Rodriguez-Sancho LC, et al. The first 50 cases of primary hyperparathyroidism treated by an endocrine surgery team. Rev Invest Clin 1997;49:179-182.
  146. Roe SM, Burns RP, Graham LD, Brock WB, Russell WL. Cost-effectiveness of preoperative localization studies in primary hyperparathyroid disease. Ann Surg 1994;219:582-586.
  147. Roses DF, Karp NS, Sudarsky LA, Valensi QJ, Rosen RJ, Blum M. Primary hyperparathyroidism associated with two enlarged parathyroid glands. Arch Surg 1989;124:1261-1265.
  148. Roses DF, Sudarsky LA, Sanger J, Raghavendra BN, Reede DL, Blum M. The use of preoperative localization of adenomas of the parathyroid glands by thallium-technetium subtraction scintigraphy, high- resolution ultrasonography and computed tomography. Surg Gyn&OB 1989;168:99-106.
  149. Rossitch JC, Cowan RJ, Ellis MB, Griffith RF. Tc-99m sestamibi for detection of parathyroid adenoma: Comparison of single and dual tracer imaging. Cl Nuc Med 1995;20:220-221.
  150. Russell CF, Laird JD, Ferguson WR. Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach? World J Surg 1990;14:406-409.
  151. Ryan JA, Eisenberg B, Pado KM, Lee F. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg 1997;132:886-891.
  152. Ryan JA Jr. et al. Effectiveness and safety of 100 consecututive parathyroidectomies. Am J Surg 1997;173:441-444.
  153. Sarfati E, Billotey C, Halimi B, Fritsch S, Cattan P, Dubost C. Early localization and reoperation for persistent primary hyperparathyroidism. Br J Surg 1997;84:98-100.
  154. Scott-Coombes DM, et al. Surgical treatment of parathyroid disease. Br J Hosp Med 1997;57:488-491.
  155. Serchuk LS, et al. SPECT and subtraction imaging of an ectopic parathyroid adenoma. Clin Nucl Med 1997;22:459-462.
  156. Serpell JW, Campbell PR, Young AE. Preoperative localization of parathyroid tumors does not reduce operating time. Br. J. Surg. 1991;78:589-590.
  157. Sfakianakis GN, Irvin GL, Foss J, Mallin W, Deriso GT, Molinari AS, Ezuddin S, Ganz W, Serafini A, Jabir AM, Chandarlapaty SKC. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. Journal of Nuclear Medicine 1996;37:798-804.
  158. Shaha AR, Sarkar S, Strashun A, Yeh S. Sestamibi scan for preoperative localization in primary hyperparathyroidism. Head & Neck 1997;19:87-91.
  159. Shen W, Duren M, Morita E, Higgins C, Duh QY, Siperstein AE, Clark OH. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 1996;131:861-869.
  160. Shen W, Sabanci U, Morita ET, Siperstein AE, Duh QY, Clark OH. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 1997;132:969-976.
  161. Silver CE, Velez FJ. Parathyroid re-exploration. Am J Surg 1992;164:606-609.
  162. Silverberg SJ, Bilezikian JP. Primary hyperparathyroidism: still evolving? Journal of Bone and Mineral Research 1997;12:856-862.
  163. Sinha CK, Hamaker R, Hamaker RC, Freeman SB, Borrowdale RW, Huntley TC. Utility of preoperative radionuclide scanning for primary hyperparathyroidism. Laryngoscope 1997;107:753-758.
  164. Skinner KA, Zuckerbraun L. Recurrent secondary hyperparathyroidism: An argument for total parathyroidectomy. Arch Surg 1996;131:724-727.
  165. Sofferman RA, Nathan MH, Fairbank JT, Foster RS, Krag DN. Preoperative technetium Tc 99m sestamibi imaging: Paving the way to minimal-access parathyroid surgery. Arch Otolaryngol Head Neck Surg 1996;122:369-374.
  166. Staudenherz A, Telfeyan D, Steiner E, Niederle B, Leitha T, Kletter K. Scintigraphic pitfalls in giant parathyroid glands. J Nucl Med 1995;36:467-469.
  167. Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S, Kaserer K, Becherer A, Leitha T, Kletter K. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997;24:143-149.
  168. Stein MS, et al. Large, rapid skeletal changes after parathyroidectomy. Clin Nephrol 1997;48:191-194.
  169. Summers GW. Parathyroid Exploration: A review of 125 cases. Arch Otolaryngol Head Neck Surg. 1991:117:1237-1241.
  170. Summers GW, Dodge DL, Kammer H. Accuracy and cost-effectiveness of preoperative isotope and ultrasound imaging in primary hyperparathyroidism. Oto Head and Neck Surg 1989;100:210-217.
  171. Summers GW. Parathyroid update: A review of 220 cases. ENT 1996;75:434-439.
  172. Sutter CW, Shelton DK. Four ectopic parathyroid glands detected with Tc-99m sestamibi. Cl Nucl Med 1997;22:120-121.
  173. Suzuki T, et al. A thymoma associated with hyperparathyroidism. Thorac Cardiovasc Surg 1997;45:211-212.
  174. Taillefer R, Boucher Y, Potvin C, Lamber R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m- sestamibi (double-phase study). J Nucl Med 1992;33:1801-1807.
  175. Takami H. Surgical management of hyperparathyroidism in view of a reliable parathyroid adenoma localization test. Surgery 1997; 122:120.
  176. Takami H. Technetium 99m sestamibi scan is the useful procedure to locate parathyroid adenomas before surgery. Am J Surgery 1996;172:93.
  177. Tanaka Y, et al. Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism. Semin Surg Oncol 1997;13:125-133.
  178. Tezelman S, Shen W, Shaver JK, Siperstein AE, Duh Q, Klein H, Clark OH. Double parathyroid adenomas: Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg 1993;218:300-309.
  179. Thomas CG. Presidential address: The glands of Owen--A perspective on the history of hyperparathyroidism. Surg 1990;108:939-950.
  180. Thompson GB, Mullan BP, Grant CL, Gorman CA, vanHeerden JA, O'Connor MK, Goellner JR, Ilstrup DM. Parathyroid imaging with technetium-99m-sestamibi: An initial institutional experience. Surg 1994;116:966-973.
  181. Thompson NW. Multiple endocrine neoplasia type I. Surgical therapy. Cancer Treat Res 1997;89:407-419.
  182. Thule P, Thakore K, Vansant J, McGarity W, Weber C, Phillips LS. Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning. Journal of Clinical Endocrinology and Metablolism. 1993;78:77-82.
  183. Tibblin S, Bizard JP, Bondeson AG, Bonjer J, Bruining HA, Meier F, Proye C, quievreux JL, Rothmund M, Thompson NW, Uden P, Zielke A. Primary hyperparathyroidism due to solitary adenoma: A comparative multicentre study of early and long term results of different surgical regimens. Eur J Surg 1991;157:511-515.
  184. Tibblin S, Bondesson AG, Uden P. Current trends in the surgical treatment of solitary parathyroid adenoma: A questionnaire study from 53 surgical departments in 14 countries. Eur J Surg 1991;157:103- 107.
  185. Tibblin S, Bondeson AG, Ljungberg O. Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 1982;195:245-252.
  186. Tominaga Y, et al. Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management. Surg Today 1997;27:787-792.
  187. Tominaga Y, et al. Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management. Surg Today 1997;27:787-792.
  188. Uden P, Aspelin P, Berglund J, Lilja B, Nyman U, Olsson LE, Zederfeldt B. Preoperative localization in unilateral parathyroid surgery: A cost-benefit study on ultrasound, computed tomography, and scintigraphy. Acta Chir Scand. 1990;156:29-35.
  189. van Heerden J, Grant CS. Surgical treatment of primary hyperparathyroidism: An institutional perspective. World J Surg. 1991;15:688-692.
  190. Vojvodich SM, Lampe HB. Imaging and surgery in hyperparathyroidism: A 10-year review. The Journal of Otolaryngology. 1996;25(2):126-129.
  191. Wallfelt C, Ljunghal S, Bergstrom R, Rastad J, Akerstrom G. Clinical characteristics and surgical treatment of sporadic primary hyperparathyroidism with emphasis on chief cell hyperplasia. Surg 1990;107:13-19.
  192. Wang CA. Unilateral neck exploration for primary hyperparathyroidism. Arch Surg 1990;125:985.
  193. Waters GS, Burke GJ, Corley JH, Wei JP. In vivo uptake of Technetium-99m-Sestamibi by parathyroid glands in comparison to surrounding tissues of the neck. Am Surg 1997;63:195-198.
  194. Weber CJ, Vansant J, Alazraki N, Christy J, Watts N, Phillips LS, Mansour K, Sewell W, McGarity WC. Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surg 1993;114:1011-1018.
  195. Wei JP, Burke GJ. Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scan. Am J Surg 1995;170:488-491.
  196. Wei JP, Burke GJ, Mansberger Ar. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surg 1992;112:1111-1117.
  197. Wei JP, Burke GJ, Mansberger AR. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-Pertechnetate and Tc-99m-Sestamibi radionuclide scans. Ann Surg. 1994;219:568-73.
  198. Weigelt JA. Invited commentary. Arch Surg. 1997;132:925.
  199. Weinberger MS, Robbins T. Diagnostic localization studies for primary hyperparathyroidism: A suggested algorithm. Arch Otolaryngol Head Neck Surg. 1994;120:1187-89.
  200. Wells SA. Advances in the operative management of persistent hyperparathyroidism. Mayo Clin Proc 1991;66:1175-1177.
  201. Wells SA, Leight GS, Hensley M, Dilley WG. Hyperparathyroidism associated with the enlargement of two or three parathyroid glands. Ann Surg; 1985;202:533-538.
  202. Worsey MJ, Carty SE, Watson CG. Success of unilateral neck exploration for sporadic primary hyperparathyroidism. Surgery 1993;114:1024-30.
  203. Yamaguchi S, et al. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. J Clin Endocrinol Metab 1997;82:2681-2688.
  204. Young AE, Gaunt JI, Croft DN, Collins RE, Wells CP, Coakley AJ. Location of parathyroid adenomas by thallium-201 and technetium-99m subtraction scanning. British Medical Journal 1983;286:1384-1386.
  205. Yousem DM, Scheff AM. Thyroid and parathyroid gland pathology. Role of imaging. Otolaryngologic Clinics of North America 1995;28:621-49.
  206. Zuback J, Patel KA, Guzman R, Thakur N, Zonszein J. Preoperative localization of a parathyroid adenoma with Tc-99m sestamibi imaging in a patient with concomitant nontoxic multinodular goiter. Cl Nucl Med 1995;20:27-30.
The authors wish to thank EndocrineWeb for providing this space.